Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial

Stephen Couban

doi:10.1016/S1470-2045(15)00462-3

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial

Stephen Couban

Pharmacology, Toxicology and Pharmaceutics

科研成果: 期刊稿件 › 文章 › 同行评审

302 引用（Scopus）

源语言	英语
页（从-至）	164-173
页数	10
期刊	The Lancet Oncology
卷	17
期	2
DOI	https://doi.org/10.1016/S1470-2045(15)00462-3
出版状态	已出版 - 2月 1 2016

!!!ASJC Scopus Subject Areas

肿瘤学

访问文件

10.1016/S1470-2045(15)00462-3

其它文件与链接

指纹

探究 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial' 的科研主题。它们共同构成独一无二的指纹。

引用此

Couban, S. (2016). Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial. The Lancet Oncology, 17(2), 164-173. https://doi.org/10.1016/S1470-2045(15)00462-3

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial. / Couban, Stephen.
在: The Lancet Oncology, 卷 17, 号码 2, 01.02.2016, 页码 164-173.

科研成果: 期刊稿件 › 文章 › 同行评审

Couban, S 2016, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, 卷 17, 号码 2, 页码 164-173. https://doi.org/10.1016/S1470-2045(15)00462-3

@article{900261fcd85c4d5ebde63f4221b5546b,

title = "Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial",

author = "Stephen Couban",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Ltd.",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/S1470-2045(15)00462-3",

language = "English",

volume = "17",

pages = "164--173",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

TY - JOUR

T1 - Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors

T2 - A randomised, controlled, open-label, phase 3, multicentre trial

AU - Couban, Stephen

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84959347862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959347862&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)00462-3

DO - 10.1016/S1470-2045(15)00462-3

M3 - Article

C2 - 26723083

AN - SCOPUS:84959347862

SN - 1470-2045

VL - 17

SP - 164

EP - 173

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -